Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Deoxyribozyme Strategy Applied to Infectious Pathogen Detection

By LabMedica International staff writers
Posted on 14 Mar 2013
A novel strategy has integrated two emerging technologies for point-of-care (POC) analysis of infectious disease targets.

The combination of colorimetric coupling of surface plasmons of gold nanoparticles with deoxyribozymes (DNAzyme) signal amplification technology creates a fast and simple detection method for genetic targets with a simple colorimetric readout.

Scientists at the University of Toronto (ON, Canada) have generated a rapid-diagnostic biosensor that will allow technicians to test for multiple diseases at one time with one small sample, and with high accuracy and sensitivity. More...
The biosensor relies upon gold particles in much the same vein as the average pregnancy test. With a pregnancy test, gold particles turn the test window red because the particles are linked with an antigen that detects a certain hormone in the urine of a pregnant woman.

The scientists can target a particular disease by linking gold particles with DNA strands. When a sample containing the disease gene, such as malaria, is present, it clumps the gold nanoparticles (GNP), turning the sample blue. Rather than clumping the particles together, the team immerses the gold particles in a DNA-based enzyme solution (DNAzyme) that, when the disease gene is introduced, snips the DNA from the gold particles, turning the sample red. The linker strand includes a substrate sequence that can be cleaved by a multicomponent nucleic acid enzyme (MNAzyme), which is one of the reported DNA responsive DNAzymes.

The advantage of this method is that far less of the gene needs to be present for the solution to show noticeable color changes, amplifying detection. A single DNAzyme can snip up to 600 “links” between the target genes. Just a single drop from a biological sample such as saliva or blood can potentially be tested in parallel, so that multiple diseases can be tested in one sitting. The team has also demonstrated that they can transform the testing solution into a powder, making it light and far easier to ship than solutions, which degrade over time. Powder can be stored for years at a time, and offers hope that the technology can be developed into efficient, cheap, over-the-counter tests for diseases such as Human immunodeficiency virus (HIV) and malaria for developing countries, where access to portable diagnostics is a necessity

Warren Chan, PhD, the senior author of the study, who holds a Canada Research Chair in Nanobiotechnology, said, "There's been a lot of emphasis in developing simple diagnostics. The question is how do you make it simple enough, portable enough? Gold is the best medium, because it's easy to see. It emits a very intense color." The authors concluded the MNAzyme-GNP assay provides a simple and fast colorimetric method for detection of genetic targets of bacterial, viral, and parasitic origins with 50 pM sensitivity without the need for purification and separation steps. The study was published online on February 10, 2013, in the journal Angewandte Chemie International Edition.

Related Links:
University of Toronto



Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Automatic CLIA Analyzer
Shine i9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.